Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-demecolcine | increases expression | ISO | PDS5B (Homo sapiens) | 6480464 | Demecolcine results in increased expression of PDS5B mRNA | CTD | PMID:23649840 | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | PDS5B (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PDS5B mRNA | CTD | PMID:22079256 | (1->4)-beta-D-glucan | multiple interactions | ISO | Pds5b (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PDS5B mRNA | CTD | PMID:36331819 | 1,2-dichloroethane | increases expression | ISO | Pds5b (Mus musculus) | 6480464 | ethylene dichloride results in increased expression of PDS5B mRNA | CTD | PMID:28960355 | 1,2-dimethylhydrazine | decreases expression | ISO | Pds5b (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of PDS5B mRNA | CTD | PMID:22206623 | 1-chloro-2,4-dinitrobenzene | affects binding | ISO | PDS5B (Homo sapiens) | 6480464 | Dinitrochlorobenzene binds to PDS5B protein | CTD | PMID:32991956 | 17beta-estradiol | multiple interactions | ISO | PDS5B (Homo sapiens) | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of PDS5B mRNA | CTD | PMID:19619570 | 17beta-estradiol | decreases expression | ISO | PDS5B (Homo sapiens) | 6480464 | Estradiol results in decreased expression of PDS5B mRNA | CTD | PMID:21185374 | 17beta-estradiol | increases expression | ISO | PDS5B (Homo sapiens) | 6480464 | Estradiol results in increased expression of PDS5B mRNA | CTD | PMID:19619570 | 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | increases expression | ISO | PDS5B (Homo sapiens) | 6480464 | Metribolone results in increased expression of PDS5B mRNA | CTD | PMID:17010196 | 17beta-hydroxy-5alpha-androstan-3-one | increases expression | ISO | PDS5B (Homo sapiens) | 6480464 | Dihydrotestosterone results in increased expression of PDS5B mRNA | CTD | PMID:29581250 | 2,2',4,4'-Tetrabromodiphenyl ether | decreases expression | ISO | PDS5B (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:31675489 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | PDS5B (Homo sapiens) | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of PDS5B mRNA | CTD | PMID:19619570 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PDS5B mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PDS5B mRNA | CTD | PMID:34747641 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Pds5b (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of APRIN mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | PDS5B (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PDS5B mRNA | CTD | PMID:19619570 | 2,4,6-tribromophenol | decreases expression | ISO | PDS5B (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:31675489 | 2-palmitoylglycerol | increases expression | ISO | PDS5B (Homo sapiens) | 6480464 | 2-palmitoylglycerol results in increased expression of PDS5B mRNA | CTD | PMID:37199045 | aconitine | increases expression | EXP | | 6480464 | Aconitine results in increased expression of PDS5B protein | CTD | PMID:33236894 | acrylamide | increases expression | ISO | PDS5B (Homo sapiens) | 6480464 | Acrylamide results in increased expression of PDS5B mRNA | CTD | PMID:32763439 | aflatoxin B1 | increases expression | ISO | Pds5b (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of APRIN mRNA | CTD | PMID:19770486 | aflatoxin B1 | decreases methylation | ISO | PDS5B (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of PDS5B gene | CTD | PMID:27153756 | all-trans-retinoic acid | decreases expression | ISO | PDS5B (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of PDS5B mRNA | CTD | PMID:33167477 | antirheumatic drug | increases expression | ISO | PDS5B (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of PDS5B mRNA | CTD | PMID:24449571 | aristolochic acid A | decreases expression | ISO | PDS5B (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of PDS5B mRNA | CTD | PMID:33212167 | benzo[a]pyrene | increases expression | ISO | PDS5B (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of PDS5B mRNA | CTD | PMID:17879257 | benzo[a]pyrene | decreases expression | ISO | PDS5B (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of PDS5B mRNA | CTD | PMID:20064835 and PMID:20106945 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | PDS5B (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:19150397 and PMID:26238291 | bicalutamide | multiple interactions | ISO | PDS5B (Homo sapiens) | 6480464 | bicalutamide inhibits the reaction [Calcitriol results in increased expression of APRIN] | CTD | PMID:15754350 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of PDS5B mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of PDS5B mRNA | CTD | PMID:30816183 more ... | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with tributyltin] results in increased expression of PDS5B mRNA | CTD | PMID:31129395 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of PDS5B gene | CTD | PMID:28505145 | butanal | decreases expression | ISO | PDS5B (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of PDS5B mRNA | CTD | PMID:26079696 | cadmium atom | multiple interactions | ISO | PDS5B (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PDS5B mRNA | CTD | PMID:35301059 | cadmium dichloride | multiple interactions | ISO | PDS5B (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PDS5B mRNA | CTD | PMID:35301059 | caffeine | affects phosphorylation | ISO | PDS5B (Homo sapiens) | 6480464 | Caffeine affects the phosphorylation of PDS5B protein | CTD | PMID:35688186 | calcitriol | increases expression | ISO | PDS5B (Homo sapiens) | 6480464 | Calcitriol results in increased expression of APRIN | CTD | PMID:15754350 | calcitriol | multiple interactions | ISO | PDS5B (Homo sapiens) | 6480464 | bicalutamide inhibits the reaction [Calcitriol results in increased expression of APRIN] | CTD | PMID:15754350 | chlorpyrifos | decreases expression | ISO | Pds5b (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of PDS5B mRNA | CTD | PMID:20350560 and PMID:37019170 | chromium(6+) | decreases expression | ISO | PDS5B (Homo sapiens) | 6480464 | chromium hexavalent ion results in decreased expression of PDS5B mRNA | CTD | PMID:27793765 | cisplatin | decreases phosphorylation | ISO | Pds5b (Mus musculus) | 6480464 | Cisplatin results in decreased phosphorylation of PDS5B protein | CTD | PMID:22006019 | copper atom | increases expression | EXP | | 6480464 | Copper results in increased expression of PDS5B mRNA | CTD | PMID:30556269 | copper(0) | increases expression | EXP | | 6480464 | Copper results in increased expression of PDS5B mRNA | CTD | PMID:30556269 | copper(II) sulfate | decreases expression | ISO | PDS5B (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of PDS5B mRNA | CTD | PMID:19549813 | coumarin | affects phosphorylation | ISO | PDS5B (Homo sapiens) | 6480464 | coumarin affects the phosphorylation of PDS5B protein | CTD | PMID:35688186 | crocidolite asbestos | decreases expression | ISO | Pds5b (Mus musculus) | 6480464 | Asbestos and Crocidolite results in decreased expression of PDS5B mRNA | CTD | PMID:29279043 | cyclosporin A | decreases expression | ISO | PDS5B (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of PDS5B mRNA | CTD | PMID:20106945 | dicrotophos | decreases expression | ISO | PDS5B (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of PDS5B mRNA | CTD | PMID:28302478 | disodium selenite | increases expression | ISO | PDS5B (Homo sapiens) | 6480464 | Sodium Selenite results in increased expression of APRIN mRNA | CTD | PMID:18175754 | elemental selenium | multiple interactions | ISO | PDS5B (Homo sapiens) | 6480464 | [Selenium co-treated with Vitamin E] results in increased expression of APRIN mRNA | CTD | PMID:19244175 | elemental selenium | decreases expression | ISO | PDS5B (Homo sapiens) | 6480464 | Selenium results in decreased expression of APRIN mRNA | CTD | PMID:19244175 | fenthion | decreases expression | ISO | Pds5b (Mus musculus) | 6480464 | Fenthion results in decreased expression of PDS5B mRNA | CTD | PMID:34813904 | flutamide | decreases expression | EXP | | 6480464 | Flutamide results in decreased expression of PDS5B mRNA | CTD | PMID:24793618 | folic acid | decreases expression | ISO | Pds5b (Mus musculus) | 6480464 | Folic Acid results in decreased expression of PDS5B mRNA | CTD | PMID:25629700 | FR900359 | affects phosphorylation | ISO | PDS5B (Homo sapiens) | 6480464 | FR900359 affects the phosphorylation of PDS5B protein | CTD | PMID:37730182 | mercury atom | decreases expression | ISO | PDS5B (Homo sapiens) | 6480464 | Mercury results in decreased expression of PDS5B mRNA | CTD | PMID:16823088 | mercury(0) | decreases expression | ISO | PDS5B (Homo sapiens) | 6480464 | Mercury results in decreased expression of PDS5B mRNA | CTD | PMID:16823088 | methidathion | decreases expression | ISO | Pds5b (Mus musculus) | 6480464 | methidathion results in decreased expression of PDS5B mRNA | CTD | PMID:34813904 | methylmercury chloride | decreases expression | ISO | PDS5B (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of PDS5B mRNA | CTD | PMID:28001369 | N(4)-hydroxycytidine | decreases expression | ISO | Pds5b (Mus musculus) | 6480464 | N(4)-hydroxycytidine results in decreased expression of PDS5B mRNA | CTD | PMID:37748715 | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of PDS5B mRNA | CTD | PMID:25729387 | paracetamol | affects expression | ISO | Pds5b (Mus musculus) | 6480464 | Acetaminophen affects the expression of PDS5B mRNA | CTD | PMID:17562736 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of PDS5B mRNA | CTD | PMID:33387578 | paracetamol | decreases expression | ISO | PDS5B (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of PDS5B mRNA | CTD | PMID:21420995 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Pds5b (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PDS5B mRNA | CTD | PMID:36331819 | perfluorooctanoic acid | decreases expression | ISO | PDS5B (Homo sapiens) | 6480464 | perfluorooctanoic acid results in decreased expression of PDS5B protein | CTD | PMID:26879310 | potassium chromate | decreases expression | ISO | PDS5B (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of PDS5B mRNA | CTD | PMID:22079256 | potassium chromate | multiple interactions | ISO | PDS5B (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PDS5B mRNA | CTD | PMID:22079256 | quercetin | decreases expression | ISO | PDS5B (Homo sapiens) | 6480464 | Quercetin results in decreased expression of PDS5B mRNA | CTD | PMID:21632981 | quercetin | increases phosphorylation | ISO | PDS5B (Homo sapiens) | 6480464 | Quercetin results in increased phosphorylation of PDS5B protein | CTD | PMID:35688186 | resveratrol | multiple interactions | ISO | PDS5B (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of PDS5B mRNA | CTD | PMID:23557933 | selenium atom | multiple interactions | ISO | PDS5B (Homo sapiens) | 6480464 | [Selenium co-treated with Vitamin E] results in increased expression of APRIN mRNA | CTD | PMID:19244175 | selenium atom | decreases expression | ISO | PDS5B (Homo sapiens) | 6480464 | Selenium results in decreased expression of APRIN mRNA | CTD | PMID:19244175 | sodium fluoride | decreases expression | ISO | Pds5b (Mus musculus) | 6480464 | Sodium Fluoride results in decreased expression of PDS5B mRNA | CTD | PMID:27862939 | thapsigargin | increases expression | ISO | Pds5b (Mus musculus) | 6480464 | Thapsigargin results in increased expression of PDS5B protein | CTD | PMID:24648495 | thapsigargin | decreases expression | EXP | | 6480464 | Thapsigargin results in decreased expression of PDS5B protein | CTD | PMID:35544339 | titanium dioxide | decreases expression | ISO | Pds5b (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of PDS5B mRNA | CTD | PMID:29264374 | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of PDS5B mRNA | CTD | PMID:25729387 | tributylstannane | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with tributyltin] results in increased expression of PDS5B mRNA | CTD | PMID:31129395 | trichostatin A | increases expression | ISO | PDS5B (Homo sapiens) | 6480464 | trichostatin A results in increased expression of PDS5B mRNA | CTD | PMID:24935251 | trichostatin A | affects expression | ISO | PDS5B (Homo sapiens) | 6480464 | trichostatin A affects the expression of PDS5B mRNA | CTD | PMID:28542535 | trovafloxacin | decreases expression | ISO | Pds5b (Mus musculus) | 6480464 | trovafloxacin results in decreased expression of PDS5B mRNA | CTD | PMID:35537566 | tungsten | decreases expression | ISO | Pds5b (Mus musculus) | 6480464 | Tungsten results in decreased expression of PDS5B mRNA | CTD | PMID:30912803 | valproic acid | decreases expression | ISO | PDS5B (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of PDS5B mRNA | CTD | PMID:23179753 and PMID:27188386 | valproic acid | affects splicing | EXP | | 6480464 | Valproic Acid affects the splicing of PDS5B mRNA | CTD | PMID:29427782 | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of APRIN mRNA | CTD | PMID:18042343 | vincristine | increases expression | ISO | PDS5B (Homo sapiens) | 6480464 | Vincristine results in increased expression of PDS5B mRNA | CTD | PMID:23649840 | vitamin E | multiple interactions | ISO | PDS5B (Homo sapiens) | 6480464 | [Selenium co-treated with Vitamin E] results in increased expression of APRIN mRNA | CTD | PMID:19244175 | |